Budesonide-Formoterol
- Generic Name
- Budesonide-Formoterol
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于支气管哮喘，主要用于慢性持续性支气管哮喘；也可在重度慢性阻塞性肺疾病使用。
- Associated Conditions
- -
- Associated Therapies
- -
Replication of the D58 Asthma Trial in Healthcare Claims Data
- First Posted Date
- 2021-05-19
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 66581
- Registration Number
- NCT04892732
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
Terminated
- Conditions
- AsthmaCOPD
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2021-09-23
- Lead Sponsor
- Orion Corporation, Orion Pharma
- Target Recruit Count
- 29
- Registration Number
- NCT04663386
- Locations
- 🇳🇴
Flattum Legesenter, Hønefoss, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath